Instil Bio, Inc. SEC filings TIL

Instil Bio, Inc. has 248 filings in SEC EDGAR's recent list, going back to Sep 30, 2019. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 13, 2026 (results of operations). The company's fiscal year ends on December 31.

Instil Bio, Inc. SEC filings
Form Description Filed Period
4 Insider transaction Jun 12, 2026 Jun 11, 2026
4 Insider transaction Jun 12, 2026 Jun 11, 2026
4 Insider transaction Jun 12, 2026 Jun 11, 2026
4 Insider transaction Jun 12, 2026 Jun 11, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 9, 2026 —
4 Insider transaction Sep 12, 2025 Sep 10, 2025
144 Notice of proposed sale Sep 10, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 12, 2025 —
4 Insider transaction May 29, 2025 May 28, 2025
4 Insider transaction May 29, 2025 May 28, 2025
4 Insider transaction May 29, 2025 May 28, 2025
4 Insider transaction May 29, 2025 May 28, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2025 —
4 Insider transaction Apr 28, 2025 Apr 25, 2025
4 Insider transaction Apr 28, 2025 Apr 25, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 13, 2025 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Oct 25, 2024 —
SC 13D/A Amended ownership over 5% (active) Oct 22, 2024 —
SC 13G Ownership over 5% (passive) Sep 27, 2024 —
SC 13G Ownership over 5% (passive) Sep 27, 2024 —
4 Insider transaction Sep 23, 2024 Sep 18, 2024
4 Insider transaction Sep 23, 2024 Sep 18, 2024
4 Insider transaction Jun 13, 2024 Jun 13, 2024
4 Insider transaction Jun 13, 2024 Jun 13, 2024
4 Insider transaction Jun 13, 2024 Jun 13, 2024
4 Insider transaction Jun 13, 2024 Jun 13, 2024
SC 13G Ownership over 5% (passive) Apr 2, 2024 —
4 Insider transaction Feb 13, 2024 Feb 10, 2024
4 Insider transaction Feb 13, 2024 Feb 10, 2024
4 Insider transaction Jan 10, 2024 Jun 14, 2023
4 Insider transaction Jan 10, 2024 Jun 14, 2023
4 Insider transaction Jan 10, 2024 Jun 14, 2023
4 Insider transaction Jan 10, 2024 Jun 14, 2023
4 Insider transaction Jan 10, 2024 Jun 14, 2023
SC 13G/A Amended ownership over 5% (passive) Apr 10, 2023 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2023 —
SC 13G/A Amended ownership over 5% (passive) Feb 9, 2023 —
4/A Form 4/a Jan 20, 2023 Mar 4, 2022
4/A Form 4/a Jan 20, 2023 Mar 4, 2022
4 Insider transaction Jan 20, 2023 Jan 8, 2023
4 Insider transaction Jan 20, 2023 Jan 8, 2023
4 Insider transaction Jan 20, 2023 Jan 8, 2023
4 Insider transaction Sep 6, 2022 Sep 6, 2022
3 Initial insider ownership Sep 6, 2022 Sep 6, 2022
SC 13G Ownership over 5% (passive) Jun 22, 2022 —
4 Insider transaction May 25, 2022 May 20, 2022
4 Insider transaction May 25, 2022 May 20, 2022
4 Insider transaction May 25, 2022 May 20, 2022
4 Insider transaction May 25, 2022 May 20, 2022
4 Insider transaction May 25, 2022 May 20, 2022
4 Insider transaction May 25, 2022 May 20, 2022
3 Initial insider ownership May 3, 2022 May 3, 2022
4 Insider transaction Mar 17, 2022 Mar 15, 2022
4 Insider transaction Mar 7, 2022 Mar 4, 2022
4 Insider transaction Mar 7, 2022 Mar 4, 2022
4 Insider transaction Mar 7, 2022 Mar 4, 2022
4 Insider transaction Mar 7, 2022 Mar 4, 2022
SC 13G/A Amended ownership over 5% (passive) Feb 9, 2022 —
SC 13G Ownership over 5% (passive) Nov 10, 2021 —
4 Insider transaction Oct 8, 2021 Oct 7, 2021
4 Insider transaction Sep 13, 2021 Sep 10, 2021
4 Insider transaction May 13, 2021 Apr 30, 2021
4 Insider transaction May 13, 2021 May 11, 2021
4 Insider transaction May 13, 2021 May 11, 2021
4 Insider transaction May 13, 2021 May 11, 2021
SC 13G Ownership over 5% (passive) Apr 15, 2021 —
SC 13D Ownership over 5% (active) Apr 5, 2021 —
SC 13G Ownership over 5% (passive) Apr 1, 2021 —
SC 13D Ownership over 5% (active) Apr 1, 2021 —
4 Insider transaction Mar 25, 2021 Mar 23, 2021
4 Insider transaction Mar 25, 2021 Mar 23, 2021
4 Insider transaction Mar 25, 2021 Mar 23, 2021
4 Insider transaction Mar 25, 2021 Mar 23, 2021
4 Insider transaction Mar 25, 2021 Mar 23, 2021
4 Insider transaction Mar 25, 2021 Mar 23, 2021
4 Insider transaction Mar 22, 2021 Mar 18, 2021
4 Insider transaction Mar 22, 2021 Mar 18, 2021
4 Insider transaction Mar 22, 2021 Mar 18, 2021
4 Insider transaction Mar 22, 2021 Mar 18, 2021
4 Insider transaction Mar 22, 2021 Mar 18, 2021
4 Insider transaction Mar 22, 2021 Mar 18, 2021
4 Insider transaction Mar 22, 2021 Mar 18, 2021
4 Insider transaction Mar 22, 2021 Mar 18, 2021
4 Insider transaction Mar 22, 2021 Mar 18, 2021
4 Insider transaction Mar 22, 2021 Mar 18, 2021
3/A Form 3/a submission Mar 22, 2021 Mar 18, 2021
3/A Form 3/a submission Mar 22, 2021 Mar 18, 2021
3/A Form 3/a submission Mar 22, 2021 Mar 18, 2021
3/A Form 3/a submission Mar 22, 2021 Mar 18, 2021
3/A Form 3/a submission Mar 22, 2021 Mar 18, 2021
3/A Form 3/a submission Mar 22, 2021 Mar 18, 2021
3 Initial insider ownership Mar 18, 2021 Mar 18, 2021
3 Initial insider ownership Mar 18, 2021 Mar 18, 2021
3 Initial insider ownership Mar 18, 2021 Mar 18, 2021
3 Initial insider ownership Mar 18, 2021 Mar 18, 2021
3 Initial insider ownership Mar 18, 2021 Mar 18, 2021
3 Initial insider ownership Mar 18, 2021 Mar 18, 2021
3 Initial insider ownership Mar 18, 2021 Mar 18, 2021
3 Initial insider ownership Mar 18, 2021 Mar 18, 2021
3 Initial insider ownership Mar 18, 2021 Mar 18, 2021
3 Initial insider ownership Mar 18, 2021 Mar 18, 2021
3 Initial insider ownership Mar 18, 2021 Mar 18, 2021
3 Initial insider ownership Mar 18, 2021 Mar 18, 2021

Showing 106 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
TIL (Nasdaq)
Fiscal year ends
December 31
Incorporated in
NY
Headquarters
Dallas, TX
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
1789769

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.